Normalised Returns
Healthcare Service Provider · closest in market valueLALPATHLAB+24.6%Nifty Pharma+25.7%
Full Comparison
NSE filings · last close| Company | Price | Mkt Cap | P/E | P/B | ROE | Margin | Rev YoY | PAT YoY | D/E | 1Y Rtn |
|---|---|---|---|---|---|---|---|---|---|---|
| LALPATHLAB ● | ₹1,952 | ₹32,721 Cr | 59.9× | 13.05× | 21.8% | 18.5% | +19.1% | +27.2% | 0.00× | +24.6% |
| VIJAYA | ₹1,514 | ₹15,574 Cr | 83.1× | 16.27× | 19.7% | 21.2% | +22.8% | +37.6% | 0.00× | +48.6% |
| METROPOLIS | ₹582.6 | ₹12,079 Cr | 59.6× | 7.98× | 13.4% | 11.6% | +16.6% | +25.7% | 0.01× | +15.3% |
| THYROCARE | ₹566.85 | ₹9,023 Cr | 51.3× | 15.41× | 28.8% | 19.6% | +24.3% | +34.1% | 0.00× | +44.6% |
| NEPHROPLUS | ₹696.65 | ₹6,990 Cr | – | 6.26× | 6.9% | 7.7% | – | – | 0.07× | – |
| SURAKSHA | ₹343.3 | ₹1,788 Cr | 49.7× | 7.30× | 13.8% | 10.1% | +20.7% | +40.0% | 0.01× | +15.0% |
Healthcare Service Provider: the companies closest in market value, of the 9 in that basic industry whose filings we hold, from each company's NSE filings and the last close. Quarterly figures are for Q1 FY27; ROE, margin for FY26; P/B and D/E on the latest balance sheet. Green and red mark the two ends of a column; valuation and leverage columns are left plain. Hover a heading for its definition.
Against Healthcare Service Provider9 companies
P/E59.1×
18.6×median 55.5× · 3 of 6, highest first86.1×
P/B12.9×
1.45×median 7.51× · 3 of 9, highest first16.9×
ROE21.8%
-4.1%median 14.7% · 2 of 7, highest first30.0%
Net margin18.9%
-1.8%median 12.0% · 3 of 7, highest first21.9%
Revenue growth14.3%
10.2%median 21.1% · 6 of 7, highest first28.8%
Profit growth5.4%
5.4%median 22.9% · 6 of 6, highest first39.7%
Debt / equity0.00×
0.00×median 0.01× · 7 of 9, highest first0.55×
Dividend yield1.0%
0.1%median 0.6% · 2 of 6, highest first2.5%
1-year price change19.7%
-32.5%median 15.0% · 3 of 7, highest first45.5%
Everyone in Healthcare Service Provider whose filings we hold: 9 companies, its basic industry within Healthcare. Figures as the screener works them out (the last four quarters' profit, the latest balance sheet, the last close), so ROE can differ a little from the Financials tab's latest-year figure. A place in the line is a fact about a number, not a view on the company.
LALPATHLAB Rankings
Among 6 companies compared
Profitability
2
ROE 21.8%2nd highest of 63
Net margin 18.5%3rd highest of 6Growth
4
Revenue YoY +19.1%4th highest of 54
Net profit YoY +27.2%4th highest of 5Leverage
1
Debt / equity 0.00×Lowest of 6Valuation
4
P/E 59.9×4th lowest of 54
P/Book 13.05×4th lowest of 6Price
3
1-year return +24.6%3rd highest of 5Position 1 is the lowest NPA, multiple or leverage, and the highest return, growth or profitability figure. These are positions among the companies listed here, not a view on the stock.